View Post

Sarah Cannon Expert Comments on Former President Carter’s Cancer Announcement

Dr. Johanna Bendell, Director of the GI Cancer Research Program and Associate Director of the Drug Development Program at Sarah Cannon Research Institute – the research arm of HCA’s global cancer enterprise Sarah Cannon – was featured on CNN, Fox News, and MSNBC Thursday morning to provide insight on former U.S. President Jimmy Carter’s recent…
View Post
View Post

Sarah Cannon Featured on Fox & Friends

Sarah Cannon cancer experts and leadership appeared on Fox & Friends on Wednesday, April 29 to discuss the encouraging advances being made in cancer care. Sarah Cannon, HCA’s global cancer enterprise, is a world leader in clinical trials and immunotherapy, conducting more than 500 clinical trials annually. In the Fox & Friends segment, Sarah Cannon’s…
View Post
View Post

HCA Medical Breakthrough: How Clinical Trials at Sarah Cannon are Leading to New Breakthroughs in Cancer Therapies

Breakthroughs in cancer research have been gaining momentum over the last few years, and particularly in 2014 when the U.S. Food and Drug Administration (FDA) approved 19 new cancer drugs. Sarah Cannon, HCA’s global cancer enterprise, was instrumental in advancing 13 of these new therapies through clinical trials prior to their original FDA approval. Over…
View Post